Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥20.2bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥38.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥18.6bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥939m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥929m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.1bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥1.9bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥905m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.1bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥906m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥755m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥590m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥755m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥590m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥30.8bnat 2023-09-30Cons.Assets
Total assets¥28.7bnat 2023-03-31Cons.Assets
Total assets¥28.3bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥16.7bnat 2023-09-30Cons.Liabilities
Total liabilities¥16.1bnat 2023-03-31Cons.Liabilities
Net assets / equity¥14.1bnat 2023-09-30Cons.Net assets
Net assets / equity¥12.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥12.0bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥5.8bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥4.9bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥5.8bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥4.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥4.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥4.6bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥2.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.8bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥716m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥686m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥849m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥84.562023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.912023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥141.122022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.042022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.122022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio45.8%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio43.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio42.4%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 52
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥96m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥96m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥32m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥178m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥178m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥546m
jpcrp040300-q2r_E02752-000Electronicsreportable segmentrevenue2023-04-01 → 2023-09-30¥8.8bn
jpcrp040300-q2r_E02752-000Electronicsreportable segmentrevenue external2023-04-01 → 2023-09-30¥8.8bn
jpcrp040300-q2r_E02752-000Electronicsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥28m
jpcrp040300-q2r_E02752-000Electronicsreportable segmentsegment profit2023-04-01 → 2023-09-30¥605m
jpcrp040300-q2r_E02752-000Mobilityreportable segmentrevenue2023-04-01 → 2023-09-30¥8.1bn
jpcrp040300-q2r_E02752-000Mobilityreportable segmentrevenue external2023-04-01 → 2023-09-30¥8.1bn
jpcrp040300-q2r_E02752-000Mobilityreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥53m
jpcrp040300-q2r_E02752-000Mobilityreportable segmentsegment profit2023-04-01 → 2023-09-30¥768m
jpcrp040300-q2r_E02752-000Precision Medical Machineryreportable segmentrevenue2023-04-01 → 2023-09-30¥3.4bn
jpcrp040300-q2r_E02752-000Precision Medical Machineryreportable segmentrevenue external2023-04-01 → 2023-09-30¥3.4bn
jpcrp040300-q2r_E02752-000Precision Medical Machineryreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥0
jpcrp040300-q2r_E02752-000Precision Medical Machineryreportable segmentsegment profit2023-04-01 → 2023-09-30¥79m
—segment totalrevenue2023-04-01 → 2023-09-30¥20.3bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥20.2bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥82m
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥20.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥20.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥178m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥1.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥99m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥99m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥42m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥179m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥179m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥518m
jpcrp040300-q2r_E02752-000Electronicsreportable segmentrevenue2022-04-01 → 2022-09-30¥8.5bn
jpcrp040300-q2r_E02752-000Electronicsreportable segmentrevenue external2022-04-01 → 2022-09-30¥8.4bn
jpcrp040300-q2r_E02752-000Electronicsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥31m
jpcrp040300-q2r_E02752-000Electronicsreportable segmentsegment profit2022-04-01 → 2022-09-30¥669m
jpcrp040300-q2r_E02752-000Mobilityreportable segmentrevenue2022-04-01 → 2022-09-30¥7.3bn
jpcrp040300-q2r_E02752-000Mobilityreportable segmentrevenue external2022-04-01 → 2022-09-30¥7.3bn
jpcrp040300-q2r_E02752-000Mobilityreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥46m
jpcrp040300-q2r_E02752-000Mobilityreportable segmentsegment profit2022-04-01 → 2022-09-30¥812m
jpcrp040300-q2r_E02752-000Precision Medical Machineryreportable segmentrevenue2022-04-01 → 2022-09-30¥2.9bn
jpcrp040300-q2r_E02752-000Precision Medical Machineryreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.9bn
jpcrp040300-q2r_E02752-000Precision Medical Machineryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥2m
jpcrp040300-q2r_E02752-000Precision Medical Machineryreportable segmentsegment profit2022-04-01 → 2022-09-30−¥77m
—segment totalrevenue2022-04-01 → 2022-09-30¥18.7bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥18.6bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥80m
—segment totalsegment profit2022-04-01 → 2022-09-30¥1.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥18.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥18.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥179m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥1.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 555
ItemContextValueUnit
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass